| Wartość aktywów (mln USD): | 473 |
| Liczba spółek: | 25 |
| Stopa dywidendy: | - % |
| Opłata za zarządzanie:: | 0.36 % |
| Klasa aktywów: | Equity |
ISIN: US92189F6925
Wystawca ETF: VanEckhttps://www.vaneck.com/us/en/investments/pharmaceutical-etf-pph/
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y |
|---|
| Sektor | Udział % |
|---|---|
| Gotówka | 0.0 |
| Usługi Dystrybucyjne | 13.9 |
| Technologie Medyczne | 86.1 |
| Nazwa firmy | Symbol | Wartość | Udział % w portfelu | Ilość akcji |
|---|---|---|---|---|
| Eli Lilly & Co | LLY | 289 928 621 | 24.9 | 273 595 |
| Novartis Ag | NVS | 101 221 762 | 8.7 | 795 081 |
| Merck & Co Inc | MRK | 90 795 186 | 7.8 | 928 756 |
| Novo Nordisk A/S | NVO | 69 562 757 | 6.0 | 1 460 482 |
| Mckesson Corp | MCK | 56 989 970 | 4.9 | 65 806 |
| Gsk Plc | GSK | 54 124 712 | 4.6 | 1 146 953 |
| Johnson & Johnson | JNJ | 53 879 555 | 4.6 | 264 245 |
| Pfizer Inc | PFE | 52 602 103 | 4.5 | 2 100 723 |
| Astrazeneca Plc | AZN | 52 310 531 | 4.5 | 574 841 |
| Abbvie Inc | ABBV | 51 863 223 | 4.4 | 219 499 |
| Sanofi Sa/France | SNY | 48 887 634 | 4.2 | 985 042 |
| Bristol-Myers Squibb Co | BMY | 45 568 413 | 3.9 | 985 263 |
| Cencora Inc | COR | 45 226 571 | 3.9 | 123 678 |
| Zoetis Inc | ZTS | 37 942 717 | 3.3 | 310 853 |
| Haleon Plc | HLN | 33 524 738 | 2.9 | 3 396 630 |
| Takeda Pharmaceutical Co Ltd | TAK | 26 682 155 | 2.3 | 1 865 885 |
| Teva Pharmaceutical Industries Ltd | TEVA | 22 265 888 | 1.9 | 919 698 |
| Jazz Pharmaceuticals Plc | JAZZ | 7 498 470 | 0.6 | 42 381 |
| Viatris Inc | VTRS | 6 445 108 | 0.6 | 623 318 |
| Elanco Animal Health Inc | ELAN | 5 052 129 | 0.4 | 227 062 |
| Axsome Therapeutics Inc | AXSM | 4 113 186 | 0.4 | 27 524 |
| Corcept Therapeutics Inc | CORT | 4 071 405 | 0.3 | 52 677 |
| Other/Cash | 1 660 692 | 0.1 | 0 | |
| Bausch Health Cos Inc | BHC | 1 289 702 | 0.1 | 213 881 |
| Organon & Co | OGN | 1 226 865 | 0.1 | 170 398 |
| Perrigo Co Plc | PRGO | 885 040 | 0.1 | 70 019 |
| -USD CASH.undefined | 313 | 0.0 | 314 |